<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01177189</url>
  </required_header>
  <id_info>
    <org_study_id>E6910-R</org_study_id>
    <nct_id>NCT01177189</nct_id>
  </id_info>
  <brief_title>Oxidative Stress Links Aging, Activity, and Mobility Limitation</brief_title>
  <official_title>Oxidative Stress Links Aging, Activity and Mobility Limitation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VA Office of Research and Development</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Utah</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>VA Office of Research and Development</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to understand why and how oxidative stress negatively impacts
      mobility in the elderly, and to determine whether antioxidant supplements can increase
      vascular health and mobility.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      With the premise that U.S. Veteran demographics reveal an aging population with significant
      mobility limitation and oxidative stress is tightly linked to both of these characteristics,
      a series of skeletal muscle/vascular studies are proposed. Specifically, in a series of
      recent studies the investigators' group has documented positive vascular consequences of
      antioxidant supplementation during exercise in older subjects that negatively impacted young
      people. Further provocative findings revealed that following exercise training the older
      subjects were now also negatively impacted by the antioxidant supplementation. These findings
      have implications for the understanding of the complex balance between the positive effects
      of exercise-based rehabilitation, exercise induced oxidative stress, aging, frailty, and
      subsequent mobility limitation. Therefore four specific aims are proposed that will answer
      the questions of where (I) oxidative stress is most prevalent in the elderly, why (II)
      oxidative stress occurs in the elderly, what (III) are the acute consequences of oxidative
      stress in the elderly, and finally how (IV) can exercise-induced oxidative stress as the
      result of exercise training in elderly be appropriately managed with exogenous antioxidant
      therapy to promote compliance and the positive outcome of increased mobility.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Inadequate effect size.
  </why_stopped>
  <start_date type="Actual">July 1, 2011</start_date>
  <completion_date type="Actual">July 3, 2017</completion_date>
  <primary_completion_date type="Actual">July 3, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>Participants will consume either a daily oral antioxidant cocktail or a placebo. The oral antioxidant cocktail consists of vitamin C, vitamin E, and alpha lipoic acid.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Vascular Function (i.e. % Flow Mediated Vasodilation)</measure>
    <time_frame>8 weeks</time_frame>
    <description>The effect on flow mediated vasodilation is measured using Doppler ultrasound.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Exercise-induced Oxidative Stress (i.e. Free Radical Concentrations and Levels of Lipid Peroxidation)</measure>
    <time_frame>8 weeks</time_frame>
    <description>Free radicals and levels of lipid peroxidation were measured using electron paramagnetic spectroscopy and ELISA assays.
A minimum value is 0 and a maximum value is 10. A higher value is a worse outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vascular Function Following the Antioxidant Intervention</measure>
    <time_frame>8 weeks</time_frame>
    <description>The degree of vasodilation following the antioxidant intervention measured by Doppler ultrasound.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">87</enrollment>
  <condition>Aging</condition>
  <arm_group>
    <arm_group_label>Arm 1</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Young healthy men and women aged 18-30</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 2</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Older healthy men and women aged &gt;70.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Vitamins C, E, and alpha lipoic acid</intervention_name>
    <description>Oral antioxidant cocktail or placebo to be consumed daily</description>
    <arm_group_label>Arm 1</arm_group_label>
    <arm_group_label>Arm 2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy men and women aged either between 18 - 30 years (young group) and &gt;70 years
             (old group)

          -  Free of overt disease. Subjects will be non-obese (BMI &lt; 30) and have plasma glucose
             concentrations &lt; 7.0 mmol/L under fasting conditions and &lt; 11.1 mmol/L at 120 minutes
             of an oral glucose tolerance test (OGTT)

          -  Subjects will be sedentary, defined here as no regular physical activity for at least
             the prior 2 years

          -  Candidates must have no orthopedic limitations that would prohibit them from
             performing cycle or knee-extensor exercise

          -  All women will be postmenopausal (either natural or surgical) defined as a cessation
             of menses for at least 2 years, and in women without a uterus, follicle stimulating
             hormone (FSH) &gt; 40 IU/L

        Exclusion Criteria:

          -  Candidates demonstrating dyslipidemia based on the National Cholesterol Education
             Program Guidelines of plasma total cholesterol &gt; 240 mg/dl with LDL-cholesterol &gt; 160
             mg/dl will be excluded from participation

          -  Candidates who smoke or are taking medications (blood pressure medications, statins,
             antioxidants etc.) that could influence the results of the study will not be eligible

          -  In terms of diet, subjects will be asked to maintain a dietary record for one week
             prior to the pre-screening and if this reveals a diet that differs substantially from
             the &quot;typical&quot; average diet in both the young and old, the subject will not be eligible

          -  Women currently taking hormone replacement therapy (HRT) in the preceding year will be
             excluded from the proposed studies
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Russell S Richardson, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>VA Salt Lake City Health Care System, Salt Lake City, UT</affiliation>
  </overall_official>
  <removed_countries>
    <country>United States</country>
  </removed_countries>
  <verification_date>September 2017</verification_date>
  <study_first_submitted>July 30, 2010</study_first_submitted>
  <study_first_submitted_qc>August 5, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 6, 2010</study_first_posted>
  <results_first_submitted>October 9, 2018</results_first_submitted>
  <results_first_submitted_qc>October 9, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">February 21, 2019</results_first_posted>
  <last_update_submitted>October 9, 2018</last_update_submitted>
  <last_update_submitted_qc>October 9, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 21, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Oxidative Stress</keyword>
  <keyword>Free radicals</keyword>
  <keyword>Aging</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mobility Limitation</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ascorbic Acid</mesh_term>
    <mesh_term>Thioctic Acid</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>October 30, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/89/NCT01177189/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Arm 1</title>
          <description>Young healthy men and women aged 18-30
Vitamins C, E, and alpha lipoic acid: Oral antioxidant cocktail or placebo to be consumed daily</description>
        </group>
        <group group_id="P2">
          <title>Arm 2</title>
          <description>Older healthy men and women aged &gt;70.
Vitamins C, E, and alpha lipoic acid: Oral antioxidant cocktail or placebo to be consumed daily</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="42"/>
                <participants group_id="P2" count="45"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="42"/>
                <participants group_id="P2" count="45"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Arm 1</title>
          <description>Young healthy men and women aged 18-30
Vitamins C, E, and alpha lipoic acid: Oral antioxidant cocktail or placebo to be consumed daily</description>
        </group>
        <group group_id="B2">
          <title>Arm 2</title>
          <description>Older healthy men and women aged &gt;70.
Vitamins C, E, and alpha lipoic acid: Oral antioxidant cocktail or placebo to be consumed daily</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="42"/>
            <count group_id="B2" value="45"/>
            <count group_id="B3" value="87"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="42"/>
                    <count group_id="B2" value="45"/>
                    <count group_id="B3" value="87"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="42"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="42"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="45"/>
                    <measurement group_id="B3" value="45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="42"/>
                    <count group_id="B2" value="45"/>
                    <count group_id="B3" value="87"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                    <measurement group_id="B2" value="17"/>
                    <measurement group_id="B3" value="38"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                    <measurement group_id="B2" value="28"/>
                    <measurement group_id="B3" value="49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="42"/>
                    <count group_id="B2" value="45"/>
                    <count group_id="B3" value="87"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="42"/>
                    <measurement group_id="B2" value="45"/>
                    <measurement group_id="B3" value="87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Vascular Function (i.e. % Flow Mediated Vasodilation)</title>
        <description>The effect on flow mediated vasodilation is measured using Doppler ultrasound.</description>
        <time_frame>8 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Arm 1</title>
            <description>Young healthy men and women aged 18-30
Vitamins C, E, and alpha lipoic acid: Oral antioxidant cocktail or placebo to be consumed daily</description>
          </group>
          <group group_id="O2">
            <title>Arm 2</title>
            <description>Older healthy men and women aged &gt;70.
Vitamins C, E, and alpha lipoic acid: Oral antioxidant cocktail or placebo to be consumed daily</description>
          </group>
        </group_list>
        <measure>
          <title>Vascular Function (i.e. % Flow Mediated Vasodilation)</title>
          <description>The effect on flow mediated vasodilation is measured using Doppler ultrasound.</description>
          <units>percentage of vasodilation</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="42"/>
                <count group_id="O2" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.4" spread="0.6"/>
                    <measurement group_id="O2" value="5.2" spread="0.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Exercise-induced Oxidative Stress (i.e. Free Radical Concentrations and Levels of Lipid Peroxidation)</title>
        <description>Free radicals and levels of lipid peroxidation were measured using electron paramagnetic spectroscopy and ELISA assays.
A minimum value is 0 and a maximum value is 10. A higher value is a worse outcome.</description>
        <time_frame>8 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Arm 1</title>
            <description>Young healthy men and women aged 18-30
Vitamins C, E, and alpha lipoic acid: Oral antioxidant cocktail or placebo to be consumed daily</description>
          </group>
          <group group_id="O2">
            <title>Arm 2</title>
            <description>Older healthy men and women aged &gt;70.
Vitamins C, E, and alpha lipoic acid: Oral antioxidant cocktail or placebo to be consumed daily</description>
          </group>
        </group_list>
        <measure>
          <title>Exercise-induced Oxidative Stress (i.e. Free Radical Concentrations and Levels of Lipid Peroxidation)</title>
          <description>Free radicals and levels of lipid peroxidation were measured using electron paramagnetic spectroscopy and ELISA assays.
A minimum value is 0 and a maximum value is 10. A higher value is a worse outcome.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="42"/>
                <count group_id="O2" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.51" spread="0.19"/>
                    <measurement group_id="O2" value="2.7" spread="0.13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Vascular Function Following the Antioxidant Intervention</title>
        <description>The degree of vasodilation following the antioxidant intervention measured by Doppler ultrasound.</description>
        <time_frame>8 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Arm 1</title>
            <description>Young healthy men and women aged 18-30
Vitamins C, E, and alpha lipoic acid: Oral antioxidant cocktail or placebo to be consumed daily</description>
          </group>
          <group group_id="O2">
            <title>Arm 2</title>
            <description>Older healthy men and women aged &gt;70.
Vitamins C, E, and alpha lipoic acid: Oral antioxidant cocktail or placebo to be consumed daily</description>
          </group>
        </group_list>
        <measure>
          <title>Vascular Function Following the Antioxidant Intervention</title>
          <description>The degree of vasodilation following the antioxidant intervention measured by Doppler ultrasound.</description>
          <units>percentage of vasodilation</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="42"/>
                <count group_id="O2" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.8" spread="0.6"/>
                    <measurement group_id="O2" value="8.2" spread="0.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>4 years</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Arm 1</title>
          <description>Young healthy men and women aged 18-30
Vitamins C, E, and alpha lipoic acid: Oral antioxidant cocktail or placebo to be consumed daily</description>
        </group>
        <group group_id="E2">
          <title>Arm 2</title>
          <description>Older healthy men and women aged &gt;70.
Vitamins C, E, and alpha lipoic acid: Oral antioxidant cocktail or placebo to be consumed daily</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="45"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="45"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="45"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Van Reese</name_or_title>
      <organization>Salt Lake City VAMC</organization>
      <phone>801 582 1565</phone>
      <email>van.reese@hsc.utah.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

